Arecor Therapeutics (AREC)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

260.00p
   
  • Change Today:
      10.00p
  • 52 Week High: 420.00
  • 52 Week Low: 210.00
  • Currency: UK Pounds
  • Shares Issued: 30.62m
  • Volume: 987
  • Market Cap: £79.61m

Latest ShareCast News

Arecor Therapeutics begins type-2 diabetes trial

By Josh White

Date: Wednesday 22 Mar 2023

(Sharecast News) - Arecor Therapeutics announced the start of the phase one clinical trial for its ultra-rapid acting insulin candidate 'AT278' on Wednesday, with the first patient being dosed.

Arecor granted three patents in US, India

By Josh White

Date: Thursday 16 Feb 2023

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics has received patents for its novel formulations of insulin and adalimumab, it announced on Thursday.

Arecor ends 2022 in line with forecasts

By Josh White

Date: Thursday 19 Jan 2023

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics said in an update on Thursday that its financial performance for 2022 was in line with market expectations, as it closed the period with an unaudited cash balance of £12.8m.

Arecor's Tetris launches 'Ogluo' in Austria 04-Jan-2023 ShareCast
Arecor inks formulation study deal with 'leading... 10-Nov-2022 ShareCast
Arecor's Tetris launches hypoglycaemia treatment... 01-Nov-2022 ShareCast
Arecor gets two EU patents for adalimumab formul... 09-Aug-2022 ShareCast
Expectations exceeded for Arecor's two lead clin... 23-May-2022 ShareCast
Arecor granted first US patent for insulin formu... 23-Mar-2022 ShareCast
Arecor flags milestone payment from Hikma in fir... 21-Dec-2021 ShareCast
 
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

AREC Market Data

Currency UK Pounds
Share Price 260.00p
Change Today 10.00p
% Change 4.00 %
52 Week High 420.00
52 Week Low 210.00
Volume 987
Shares Issued 30.62m
Market Cap £79.61m

AREC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
49.26% below the market average49.26% below the market average49.26% below the market average49.26% below the market average49.26% below the market average
13.33% below the sector average13.33% below the sector average13.33% below the sector average13.33% below the sector average13.33% below the sector average
Price Trend
17.6% below the market average17.6% below the market average17.6% below the market average17.6% below the market average17.6% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Income Not Available
Growth
24.27% below the market average24.27% below the market average24.27% below the market average24.27% below the market average24.27% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

AREC Dividends

No dividends found

Trades for 28-Mar-2023

Time Volume / Share Price
13:10 60 @ 263.18p
12:41 120 @ 263.18p
10:13 600 @ 263.18p
10:08 6 @ 263.18p
09:40 14 @ 270.00p

AREC Key Personnel

CEO Sarah Jennifer Howell
CFO Susan Lowther

Top of Page